Figure 1
Gabapentin Capsule
Product Images NDC 80425-0079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2
This text appears to be a chart or graph showing a study measuring mean pain scores with two different doses of gabapentin and a placebo. The study had a three-week dose titration period followed by a four-week fixed dose period. The listed time periods are likely weeks or days. The chart shows baseline measurements and six additional measurements (labeled 1-6) taken throughout the study.*
Figure 3
Figure 4
Gabapentin 300mg Cap Qty 30 Ndc 80425 0079
This appears to be a packing slip for a medication called Gabapentin. The contents include 30 capsules of Gabapentin 300 mcg, packed by a company or entity named AAdvanced. The text does not provide any indication of the purpose or use of Gabapentin.*
Gabapentin 300mg Cap Qty 60 Ndc 80425 0079
This text is not readable as it does not provide sufficient information to generate a useful description. Please provide readable text for evaluation.*
Gabapentin 300mg Cap Qty 90 Ndc 80425 0079
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
